Krystin Meidell

Krystin Meidell is an experienced regulatory professional currently serving as Director of Global Regulatory Strategy at AbbVie since September 2021. Prior to this role, Krystin held various regulatory positions at Biogen from February 2018 to September 2021, including Associate Director and Senior Manager. Krystin has a comprehensive background in providing regulatory strategic support for medical devices and diagnostics across multiple companies, including R&Q, Myriad Genetics, and CR Bard. Educational qualifications include a Master of Science in Engineering Management from Tufts University and a Bachelor of Science in Chemical Engineering from Carnegie Mellon University.